|Day Low/High||92.17 / 94.42|
|52 Wk Low/High||47.71 / 97.80|
TheStreet Ratings group highlights 4 stocks pushing the drugs industry higher today.
Shares of Questcor Pharmaceuticals (Nasdaq:QCOR) were gapping up Tuesday morning with an open price 36.2% higher than Monday's closing price. The stock closed at $36.71 yesterday and opened today's trading at $50.
Questcor Pharmaceuticals was a winner within the drugs industry, rising $1.05 (3.1%) to $35.22 on light volume
Shareholders of Questcor Pharmaceuticals Inc looking to boost their income beyond the stock's 2.9% annualized dividend yield can sell the January 2014 covered call at the $45 strike and collect the premium based on the $2.30 bid, which annualizes to an additional 10.2% rate of return against the current stock price (at Stock Options Channel we call this the YieldBoost), for a total of 13.1% annualized rate in the scenario where the stock is not called away. Any upside above $45 would be lost if the stock rises there and is called away, but QCOR shares would have to climb 28% from current levels for that to happen, meaning that in the scenario where the stock is called, the shareholder has earned a 34.5% return from this trading level, in addition to any dividends collected before the stock was called.
Questcor Pharmaceuticals was a leading decliner within the health care sector, falling $0.40 (-1.1%) to $37.21 on light volume
Questcor Pharmaceuticals (Nasdaq:QCOR) is trading at unusually high volume Tuesday with 3.9 million shares changing hands. It is currently at two times its average daily volume and trading up $4.58 (+12.2%).
Questcor Pharmaceuticals (Nasdaq:QCOR) is trading at unusually high volume Wednesday with 4.5 million shares changing hands. It is currently at 2.5 times its average daily volume and trading up $1 (+3.3%).
Quarterly reports continue to roll in this coming week as investors get results from Facebook, Pfizer and General Motors. TheStreet's Brittany Umar has the details.
The most recent short interest data has been released by the NASDAQ for the 04/15/2013 settlement date, which shows a 3,094,233 share increase in total short interest for Questcor Pharmaceuticals Inc , to 27,323,913, an increase of 12.77% since 03/28/2013. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
The ex-dividend date for Questcor Pharmaceuticals (Nasdaq:QCOR) is tomorrow, April 18, 2013. Owners of shares as of market close today will be eligible for a dividend of 25 cents per share. At a price of $27.70 as of 10 a.m., the dividend yield is 3.7%.
Questcor Pharmaceuticals was a leading decliner within the health care sector, falling $1.42 (-4.5%) to $30.08 on heavy volume.
To create the stock list below we screenedÂ for companies with significant decreases in shares shorted month over month. This signals [...]
Questcor Pharmaceuticals was a winner within the drugs industry, rising 34 cents (1.1%) to $32.70 on average volume.
Cramer is avoiding Questcor Pharmaceuticals and ArcelorMittal but wants Fortune Brands Home & Security.
Questcor Pharmaceuticals was a leading decliner within the health care sector, falling 70 cents (-2.3%) to $30.10 on heavy volume.
Unusual volume can be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.
Questcor Pharmaceuticals (Nasdaq:QCOR) is trading at unusually high volume Wednesday with 3.3 million shares changing hands. It is currently at 2.1 times its average daily volume and trading up $1.80 (+5.5%).
By Rebecca Lipman, Kapitall Editor Â When short sellers "cover" their position on a stock they signalÂ optimism, meaning they believe the [...]
These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.
Questcor Pharmaceuticals (Nasdaq:QCOR) has been upgraded by TheStreet Ratings from a hold to buy.
Often when above-average volume moves into an equity, it precedes a large spike in volatility.
Questcor Pharmaceuticals (Nasdaq:QCOR) is trading at unusually high volume Friday with 3.1 million shares changing hands. It is currently at two times its average daily volume and trading up $1.34 (+4.9%).
The United States District Court for the Central District of California recently appointed Johnson & Weaver, LLP to pursue a derivative action on behalf of Questcor Pharmaceuticals Inc.
The fourth quarter earnings season has just begun. Some companies manage to consistently surprise the market with positive earnings reports. [...]
Cramer is also down on Lowe's and Questcor Pharmaceuticals but thinks Invesco Mortgage Capital is coming back.
Cramer said he's interested in building-materials and home-furnishing companies as well as beaten-down insurers.
There are some things that didn't go wrong after all, Cramer said.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.